| Literature DB >> 10467337 |
M Bonduel1, A Pozo, M Zelazko, E Raslawski, S Delfino, J Rossi, C Figueroa, F Sackmann Muriel.
Abstract
Major histocompatibility complex (MHC) class II deficiency is a rare form of primary combined immunodeficiency that can only be corrected by stem cell transplantation. We report a 4(1/2)-year-old girl with MHC class II deficiency who underwent a related CBT due to graft failure following T cell-depleted non-identical BMT. The patient is alive and well 2 years after the second transplant. A sustained hematopoietic engraftment and a progressive immune recovery have been detected. We conclude that cord blood may be an effective source of hematopoietic stem cells for patients with immuno- deficiency disorders including diseases with a high rate of graft failure.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10467337 DOI: 10.1038/sj.bmt.1701915
Source DB: PubMed Journal: Bone Marrow Transplant ISSN: 0268-3369 Impact factor: 5.483